Assisted Reproductive Technology Market Size and Forecast 2025–2033

Introduction

The global Assisted Reproductive Technology (ART) market has emerged as one of the most transformative segments within modern healthcare. According to Renub Research, the global assisted reproductive technology market size was valued at USD 27.76 billion in 2024 and is projected to reach USD 49.30 billion by 2033, expanding at a compound annual growth rate (CAGR) of 6.59% during 2025–2033.

Download Sample Report

The rapid expansion of the ART market is primarily driven by increasing infertility rates, advancements in reproductive medicine, rising awareness about fertility treatments, and supportive government policies. As lifestyle changes, delayed parenthood, and environmental factors affect fertility worldwide, more individuals and couples are turning toward assisted reproductive technologies to achieve parenthood.

In addition, the growth of specialized fertility clinics, improved success rates in procedures such as in vitro fertilization (IVF), and the increasing acceptance of fertility treatments are strengthening the global market outlook. These factors collectively contribute to the growing adoption of ART solutions worldwide.

The Assisted Reproductive Technology Market & Forecast report by Renub Research analyzes the industry by Type (In-Vitro Fertilization and Artificial Insemination), End Users (Hospitals, Fertility Clinics, and Other End Users), as well as country-level insights and company analysis for 2025–2033.

Assisted Reproductive Technology Market Overview

Assisted Reproductive Technology refers to medical procedures designed to treat infertility by handling eggs, sperm, or embryos outside the human body. These technologies have revolutionized fertility treatment and offer hope to millions of individuals facing challenges in conceiving naturally.

Common ART procedures include:

In vitro fertilization (IVF)

Artificial insemination

Egg and embryo freezing

Surrogacy arrangements

Preimplantation genetic testing

These technologies are particularly helpful for individuals affected by conditions such as hormonal disorders, reproductive organ abnormalities, genetic complications, or age-related fertility decline.

In developed economies, ART procedures are widely adopted due to advanced healthcare infrastructure, high awareness, and improved treatment success rates. Meanwhile, emerging economies such as India, Thailand, and Malaysia are becoming prominent fertility tourism destinations due to affordable treatment costs and high-quality medical services.

Additionally, ART has broadened the concept of parenthood by enabling same-sex couples and single individuals to build families through assisted reproductive techniques. Governments, healthcare institutions, and non-profit organizations are increasingly promoting fertility awareness programs and subsidies, further expanding access to fertility care.

Despite the market’s strong growth trajectory, certain barriers such as ethical debates, high treatment costs, and regulatory complexities continue to influence industry dynamics.

Key Growth Drivers of the Assisted Reproductive Technology Market

Rising Global Infertility Rates

One of the most significant drivers of the ART market is the increasing prevalence of infertility worldwide. Modern lifestyle factors such as stress, sedentary habits, obesity, delayed marriage, and environmental exposure are contributing to declining fertility rates across many countries.

Medical conditions including polycystic ovary syndrome (PCOS), endometriosis, hormonal imbalances, and male infertility disorders further increase the need for advanced fertility treatments.

According to a World Health Organization (WHO) report published in April 2023, approximately 17.5% of adults globally experience infertility, highlighting the urgent need for accessible fertility treatments.

The report also revealed that infertility rates remain consistent across income levels:

17.8% in high-income countries

16.5% in low- and middle-income countries

As awareness about fertility treatments continues to rise, more couples are exploring ART options such as IVF and artificial insemination. This growing demand is significantly expanding the global ART market.

Technological Advancements in Reproductive Medicine

Technological innovation plays a critical role in improving the effectiveness and accessibility of assisted reproductive treatments.

Recent advancements include:

Cryopreservation technology for egg and embryo freezing

Preimplantation genetic testing (PGT) for detecting genetic abnormalities

Time-lapse embryo imaging systems

Artificial intelligence-based embryo selection tools

These technologies enhance the accuracy of embryo selection, improve implantation success rates, and reduce the likelihood of complications during pregnancy.

AI-powered fertility platforms are particularly gaining traction as they help physicians analyze embryo development patterns and optimize treatment outcomes.

A notable example of innovation in the field occurred in December 2023, when Freya BioSciences raised USD 38 million to develop reproductive immunotherapies and expand its microbiome sequencing and immune biomarker data platform.

As research and development activities accelerate, future ART procedures are expected to become more efficient, safer, and increasingly personalized.

Supportive Government Policies and Insurance Coverage

Government support has become an important catalyst for the growth of assisted reproductive technology worldwide.

Many countries have begun implementing:

Subsidized fertility treatment programs

Insurance coverage for IVF procedures

Public awareness campaigns

Expanded reproductive healthcare funding

These initiatives aim to address declining birth rates and support families facing infertility challenges.

For instance, the Japanese government has introduced policies to encourage higher birth rates through the “Children’s Future Strategy.” Announced in 2023, the program aims to increase spending on children and family support by 3.6 trillion yen annually by fiscal year 2028.

The initiative also plans to expand childcare facilities and strengthen financial assistance for families, indirectly supporting the demand for fertility treatments such as ART.

Similarly, many European countries provide partial or full reimbursement for fertility treatments, making ART more accessible to patients.

Challenges in the Assisted Reproductive Technology Market

High Cost of Fertility Treatments

Despite growing adoption, the cost of assisted reproductive procedures remains a major barrier.

ART treatments—especially IVF—can involve significant expenses including:

Fertility medications

Laboratory procedures

Specialist consultations

Multiple treatment cycles

Since successful conception may require several IVF cycles, treatment costs can escalate rapidly. In many regions, limited insurance coverage makes fertility treatments inaccessible for middle- and lower-income families.

Although technological innovations aim to reduce treatment costs over time, affordability remains a critical challenge for widespread adoption.

Ethical and Legal Considerations

Ethical and regulatory issues continue to influence the development of the ART industry.

Key concerns include:

Embryo selection practices

Surrogacy regulations

Use of donor eggs or sperm

Genetic screening of embryos

Legal frameworks governing ART procedures vary widely across countries. Some regions have strict regulations regarding embryo storage, surrogacy, or fertility treatment eligibility.

In addition, religious and cultural perspectives in certain societies may discourage the use of reproductive technologies.

These regulatory inconsistencies can create operational challenges for fertility clinics and limit cross-border fertility services.

In-Vitro Fertilization (IVF) Segment Dominates the ART Market

Among ART procedures, in vitro fertilization (IVF) holds the largest market share due to its high success rate and widespread adoption.

IVF involves fertilizing an egg with sperm outside the human body in a controlled laboratory environment. The resulting embryo is then transferred into the uterus to initiate pregnancy.

Technological innovations such as embryo freezing, genetic testing, and AI-based embryo selection have significantly improved IVF success rates.

Increasing infertility cases, rising awareness of fertility treatments, and supportive healthcare policies are driving strong demand for IVF procedures worldwide. As a result, IVF continues to remain the cornerstone of the ART industry.

Artificial Insemination Market

Artificial insemination represents another important segment within the ART market. The procedure involves placing sperm directly into the uterus during ovulation to facilitate fertilization.

Artificial insemination is often recommended for:

Unexplained infertility

Mild male infertility

Mild endometriosis cases

Compared with IVF, artificial insemination is less invasive and more cost-effective, making it an attractive option for many couples beginning fertility treatment.

Growing awareness, improved medical techniques, and increasing success rates are contributing to the rising popularity of artificial insemination procedures globally.

End User Analysis

Hospitals

Hospitals play a vital role in delivering assisted reproductive technology services. Many large hospitals operate specialized fertility departments equipped with advanced laboratories and trained reproductive specialists.

Hospitals also provide integrated services including diagnostic testing, fertility counseling, and treatment monitoring.

Fertility Clinics

Specialized fertility clinics represent the fastest-growing segment of the ART market. These centers focus exclusively on reproductive medicine and offer highly specialized services such as IVF cycles, egg freezing, and donor programs.

The growth of fertility clinics is fueled by increasing patient demand for personalized fertility care and advanced treatment technologies.

Other End Users

Other end users include research institutes and academic medical centers involved in fertility research and reproductive health innovation.

These organizations play a key role in developing new fertility treatment technologies and improving clinical outcomes.

Regional Market Insights

United States

The United States represents one of the largest ART markets due to its advanced healthcare infrastructure and high adoption of fertility treatments.

Increasing awareness, expanding fertility clinics, and growing demand for egg freezing among women delaying parenthood are supporting market growth.

The country also benefits from continuous research advancements and expanding insurance coverage in certain states.

United Kingdom

The United Kingdom’s ART market is expanding steadily due to supportive healthcare policies and rising infertility rates.

The National Health Service (NHS) subsidizes certain fertility treatments, improving access to ART services. Awareness campaigns and digital healthcare platforms are further increasing patient access to fertility specialists.

In December 2023, TMRW Life Sciences entered the UK fertility market with an automated platform for frozen egg and embryo storage, highlighting ongoing technological innovation in the sector.

India

India is emerging as a major hub for fertility treatments due to affordable medical services and skilled healthcare professionals.

Factors driving the Indian ART market include:

Increasing urbanization

Changing lifestyles

Rising infertility awareness

Growing fertility tourism

The Indian government has also introduced ART Regulations 2023, aimed at improving safety standards and regulatory oversight within the fertility treatment industry.

Saudi Arabia

Saudi Arabia’s ART market is gradually expanding as healthcare infrastructure improves and awareness about infertility grows.

The country’s Vision 2030 initiative aims to modernize healthcare services and increase access to advanced medical treatments. Educational campaigns and technological advancements are also improving social acceptance of fertility treatments.

Competitive Landscape

The global assisted reproductive technology market is highly competitive, with several companies investing in technological innovation, research partnerships, and service expansion.

Key players analyzed in the report include:

Thermo Fisher Scientific Inc.

Sumitomo Mitsui Financial Group, Inc.

CooperSurgical, Inc.

Fujifilm Holdings Corporation

Merck KGaA

Progyny Inc.

Cosmos Biomedical Ltd.

Each company has been evaluated across five major perspectives:

Company overview

Key executives

Product portfolio

Strategic developments

Financial insights

Final Thoughts

The global Assisted Reproductive Technology market is entering a period of sustained growth as infertility rates rise and reproductive medicine continues to evolve.

With technological innovations improving treatment outcomes, government policies expanding access to fertility care, and specialized clinics increasing worldwide, ART is becoming an essential healthcare solution for millions of individuals seeking parenthood.

While challenges such as high treatment costs and ethical debates remain, continued advancements in medical technology and policy support are expected to further accelerate market growth.

As the industry progresses toward USD 49.30 billion by 2033, assisted reproductive technology will continue transforming the future of fertility care and offering new hope for families across the globe.